YK-4-250, a synthetic telmisartan–tempol conjugate: crystal structure of a stabilized free radical containing an angiotensin AT1 receptor inhibitor

Friedrich, S.; Kong, Y.; Musayev, F.N.; Brown, M.L.; Gupton, B.F.

doi:10.1107/S2053229626007242

Figure 3
(a) Experimentally measured YK-4-250, drawn with 50% probability displacement ellipsoids, and (b) theoretically calculated YK-4-250 via ORCA.

STRUCTURAL
CHEMISTRY

ISSN: 2053-2296

Volume 82| Part 9| September 2026| Pages 547-552

https://doi.org/10.1107/S2053229626007242

Open

access